The last month has been better than spectacular for the penny stock of ScripsAmerica, Inc. (SCRC). Closing green 16 of the last 17 trading sessions, saying that SCRC stock is on a bullish run is a bit of an understatement. Each of the last 5 sessions have all been new 52 week highs as the one year anniversary. Although ...
The penny stocks of Fannie Mae and Freddie Mac continued to lead the OTC as the top traded securities after breaking past and closing at and above their psychological resistance points of $2. Profiled when both were trading at levels below 0.35, any trader holding tightly with confidence since our alerts on Federal Home Loan Mortgage Corporation (FMCC) and Federal National ...
When it comes to hot OTC stocks, not too many can remain “in play” like marijuana stocks. While Cannabis Science Inc. (CBIS) had a tremendous start to 2012, running from 0.0196 to a high of 0.245, a gain of 1,150%, Medical Marijuana Inc. (MJNA) is just as smoking ...
At the end of 2012, we updated our coverage on the penny stock of Generex Biotechnology Corp. (GNBT) and the devastating slide the shares had been on all year. With hopes and expectations that someone would come along and drop some much needed cash into the biotech focused on treating and curing breast cancer, the news of an investor conference call scheduled for 10am today was enough ...
While 2012 has been a banner year for a number of biotech stocks and their shareholders, one company which was not as fortunate has traders studying them in hopes they may have finally reached the oversold level. The year started out great for Generex Biotechnology Corp. (GNBT) with their proprietary technology to ward of tumors in breast cancer patients gaining rave reviews. However, since the shares ...
The penny stock constipation is over and the ExLax has begun to work its charm. Shares in the POS Great Wall Builders Ltd. (OTC: GWBU) stock have begun the release the pressure and “DUMP!” From a HOD of $1.95, shares in GWBU stock have already dropped 30 cents down to $1.65 and are not even close to releasing that first bit of ...
Finally there is life in the penny stock of Generex Biotechnology Corp. (OTC: GNBT) after the Breast Cancer Vaccine makers made three seperate announcements. GNBT stock currently trading up 17.84% at 0.109 on more than 5x the 10 day aveage volume after the Company announced an End-of-Phase II meeting has been scheduled with the FDA in respect of the Phase II clinical ...
Shares in Generex Biotechnology (OTC: GNBT) have not been able to rally since their January run when the penny stock hit $0.277. We profiled GNBT as one of our penny stock picks profiled in our newsletter when shares were just $0.1575 securing a 75% gain bottom-to-top. GNBT closed with a slight gain of 0.39% at $0.13 in the ...
One penny stock profiled here as a good penny stock to watch was Generex Biotechnology Corp. (OTCBB: GNBT.OB) who filed their 10-Q yesterday for the quarter ended January 31, 2012. As most biotech companies researching cures to certain cancers, GNBT has been struggling to meet its cash requirements for years but may be on the cusp of announcing a major breakthrough in the fight against breast cancer.
On January ...
Continue Reading →
Penny Stock Generex Biotechnology Corp. (OTCBB: GNBT.OB) traded more than 3x its Average Volume today reaching as high as 0.19 at one point in the day’s trading session.
GNBT closing price today was $0.155, down -10.40% (-0.018).
GNBT traded volume of 6,024,288.
GNBT is trading:
